These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37082800)

  • 1. Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes.
    Takehana N; Fukui T; Mori Y; Hiromura M; Terasaki M; Ohara M; Takada M; Tomoyasu M; Ito Y; Kobayashi T; Yamagishi SI
    J Diabetes Investig; 2023 Jul; 14(7):856-863. PubMed ID: 37082800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the RSR 3 screen ICA™ and 2 screen ICA™ as screening assays for type 1 diabetes in Sweden.
    Törn C; Vaziri-Sani F; Ramelius A; Elding Larsson H; Ivarsson SA; Amoroso M; Furmaniak J; Powell M; Smith BR
    Acta Diabetol; 2022 Jun; 59(6):773-781. PubMed ID: 35220476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving diagnostic accuracy of 3 Screen ICA ELISA kit in the identification of Japanese type 1 diabetes.
    Kawasaki E; Jinnouchi H; Maeda Y; Okada A; Ito Y; Kawai K
    J Diabetes Investig; 2023 Sep; 14(9):1081-1091. PubMed ID: 37293690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of Individual Positive Anti-Islet Autoantibodies from 3 Screen ICA Titer.
    Kawasaki E; Jinnouchi H; Maeda Y; Okada A; Kawai K
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a new enzyme-linked immunosorbent assay system for three islet cell autoantibodies in Japanese patients with acute-onset type 1 diabetes.
    Fukui T; Takehana N; Mori Y; Hiromura M; Terasaki M; Kushima H; Takada M; Tomoyasu M; Sato N; Hayashi T; Ohara M; Kikuchi T; Ito Y; Kobayashi T; Yamagishi SI
    Endocr J; 2022 Nov; 69(11):1343-1349. PubMed ID: 35753761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin-dependent (type 1) diabetes (SPIDDM).
    Tanaka S; Okubo M; Nagasawa K; Takizawa S; Ichijo M; Ichijo S; Kaneshige M; Aida K; Shimura H; Mori Y; Kobayashi T
    Diabetol Int; 2016 Mar; 7(1):42-52. PubMed ID: 30603242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes?
    Rogowicz-Frontczak A; Zozuliłska-Ziołkiewicz D; Litwinowicz M; Niedźwiecki P; Wyka K; Wierusz-Wysocka B
    Eur J Endocrinol; 2014 Apr; 170(4):651-8. PubMed ID: 24480135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state.
    Oikawa Y; Tanaka H; Uchida J; Atsumi Y; Osawa M; Katsuki T; Kawai T; Shimada A
    Endocr J; 2017 Feb; 64(2):163-170. PubMed ID: 27760891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.
    Andersson C; Kolmodin M; Ivarsson SA; Carlsson A; Forsander G; Lindblad B; Ludvigsson J; Kockum I; Marcus C; Samuelsson U; Ortqvist E; Lernmark A; Elding Larsson H; Törn C;
    Pediatr Diabetes; 2014 Aug; 15(5):336-44. PubMed ID: 24206368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5.
    Xiang Y; Huang G; Shan Z; Pan L; Luo S; Yang L; Shi L; Li Q; Leslie RD; Zhou Z
    Acta Diabetol; 2015 Dec; 52(6):1121-7. PubMed ID: 26239144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: a comparison between parents and siblings.
    Korhonen S; Knip MM; Kulmala P; Savola K; Akerblom HK; Knip M;
    Diabetes Metab Res Rev; 2002; 18(1):43-8. PubMed ID: 11921417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
    Turner R; Stratton I; Horton V; Manley S; Zimmet P; Mackay IR; Shattock M; Bottazzo GF; Holman R
    Lancet; 1997 Nov; 350(9087):1288-93. PubMed ID: 9357409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet cell-associated autoantibodies in Ethiopians with diabetes mellitus.
    Siraj ES; Gupta MK; Yifter H; Ahmed A; Kebede T; Reja A; Abdulkadir J
    J Diabetes Complications; 2016 Aug; 30(6):1039-42. PubMed ID: 27220543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Islet Autoantibodies in Type 1 Diabetes.
    Kawasaki E
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
    Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the clinical significance and antigen specificity of insulinoma-associated antigen-2 autoantibodies between radioimmunoassay and enzyme-linked immunosorbent assay in Japanese patients with type 1 diabetes.
    Kawasaki E; Shimada A; Imagawa A; Abiru N; Awata T; Oikawa Y; Osawa H; Kawabata Y; Kozawa J; Kobayashi T; Takahashi K; Chujo D; Fukui T; Miura J; Yasuda K; Yasuda H; Kajio H; Hanafusa T; Ikegami H;
    J Diabetes Investig; 2023 Jan; 14(1):58-66. PubMed ID: 36177861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of rare islet autoantibodies on islet function in patients with latent autoimmune diabetes in adults].
    Huang G; Sun G; Yang L; Li X; Xiang Y; Zhou Z
    Zhonghua Yi Xue Za Zhi; 2015 May; 95(20):1563-7. PubMed ID: 26463602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of GADA, ZnT8A and IA-2A in patients with type 1 diabetes mellitus with thyroid disease and their correlation with thyroid autoantibodies.
    Chen J; Bao C
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(24):12051-12057. PubMed ID: 38164867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.